ストックスクリーナーアプリを入手
2.17
11.52%
-0.26
アフターアワーズ：
2.21
0.04
+1.84%
前日終値:
$2.43
開ける：
$2.43
24時間の取引高:
132.04K
Relative Volume:
0.83
時価総額：
$40.25M
収益：
$420.00K
当期純損益:
$-26.98M
株価収益率:
-0.5201
EPS:
-4.1721
ネットキャッシュフロー:
$-32.01M
1週間 パフォーマンス:
-15.02%
1か月 パフォーマンス:
-68.41%
6か月 パフォーマンス:
-95.28%
1年 パフォーマンス:
-98.94%
1日の値動き範囲:
$2.10
$2.43
1週間の範囲:
$2.10
$2.88
52週間の値動き範囲:
$2.10
$1,030.00
Kala Bio Inc Stock (KALA) Company Profile
Compare KALA vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
2.165 | 45.17M | 420.00K | -26.98M | -32.01M | -4.1721 |
VRTX
Vertex Pharmaceuticals Inc
|
435.92 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-30 | ダウングレード | Mizuho | Outperform → Neutral |
| 2025-09-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-09-29 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2025-09-08 | 開始されました | Mizuho | Outperform |
| 2025-07-11 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-03-30 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-09-14 | ダウングレード | Jefferies | Buy → Hold |
| 2020-07-23 | 開始されました | Northland Capital | Outperform |
| 2020-06-01 | 再開されました | Oppenheimer | Outperform |
| 2020-05-27 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-09 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | 開始されました | Jefferies | Buy |
すべてを表示
Kala Bio Inc (KALA) 最新ニュース
KALA Should I Buy - Intellectia AI
Kala Bio (FRA:27F) Cyclically Adjusted Price-to-FCF : (As of May. 17, 2026) - GuruFocus
Red Light Holland Corp (OP: TRUFF - FinancialContent
KALA stock hits record low – firm announces reverse split after shares fail to surpass the $1 mark - MSN
KALA BIO (KALA) files 13G/A: Baker Bros. reports 2,312 shares post-split - Stock Titan
KALA BIO, Inc. 1Q 2026: Net loss $(1.6M), Diluted EPS $(0.14) — 10-Q Summary - TradingView
KALA BIO: Q1 Earnings Snapshot - kare11.com
KALA: Q1 2026 net loss fell to $1.6M as focus shifted to AI platform and cost reductions - TradingView
KALA BIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
KALA BIO (NASDAQ: KALA) slashes R&D spend and pivots to Researgency AI platform - Stock Titan
Exclusive: Penny stock Kala Bio transitions to revenue model with AI platform launch - MSN
Total assets of KALA BIO, Inc. – LSX:A4243T - TradingView
Discontinued operations of KALA BIO, Inc. – TRADEGATE:27F - TradingView
Cash from operating activities of KALA BIO, Inc. – FWB:27F - TradingView
Asset turnover of KALA BIO, Inc. – FWB:27F - TradingView
Working capital per share of KALA BIO, Inc. – FWB:27F - TradingView
Price to book ratio of KALA BIO, Inc. – FWB:27F - TradingView
KALA BIO, Inc. Balance Sheet – TRADEGATE:27F - TradingView
Discontinued operations of KALA BIO, Inc. – LSX:A4243T - TradingView
Dilution adjustment of KALA BIO, Inc. – GETTEX:27F - TradingView
KALA BIO, Inc. Balance Sheet – LS:A4243T - TradingView
KALA BIO, Inc. Balance Sheet – GETTEX:27F - TradingView
Discontinued operations of KALA BIO, Inc. – FWB:27F - TradingView
Enterprise value to EBITDA ratio of KALA BIO, Inc. – FWB:27F - TradingView
KALA BIO, Inc. Earnings and Revenue – MUN:27F - TradingView
Why Kala Bio’s Stock Is Sinking Again - TipRanks
CapEx per share of KALA BIO INC. O.N. – MUN:27F - TradingView
EBIT per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Free cash flow per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Long term debt to total equity ratio of KALA BIO INC. O.N. – MUN:27F - TradingView
Tangible book value per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Debt to equity ratio of KALA BIO INC. O.N. – MUN:27F - TradingView
EBITDA margin % of KALA BIO INC. O.N. – MUN:27F - TradingView
Net current asset value per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Total debt per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Inventory turnover of KALA BIO INC. O.N. – MUN:27F - TradingView
Operating cash flow per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Cash per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Working capital per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Revenue per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Price to cash flow ratio of KALA BIO INC. O.N. – MUN:27F - TradingView
EBITDA per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Gross margin % of KALA BIO INC. O.N. – MUN:27F - TradingView
Cost of goods sold of KALA BIO INC. O.N. – MUN:27F - TradingView
Non-controlling/minority interest of KALA BIO INC. O.N. – MUN:27F - TradingView
Diluted earnings per share (diluted EPS) of KALA BIO INC. O.N. – MUN:27F - TradingView
Average basic shares outstanding of KALA BIO INC. O.N. – MUN:27F - TradingView
Taxes of KALA BIO INC. O.N. – MUN:27F - TradingView
Diluted shares outstanding of KALA BIO INC. O.N. – MUN:27F - TradingView
Discontinued operations of KALA BIO INC. O.N. – MUN:27F - TradingView
Diluted net income available to common stockholders of KALA BIO INC. O.N. – MUN:27F - TradingView
Kala Bio Inc (KALA) 財務データ
収益
当期純利益
現金流量
EPS
1.49%
0.12%
大文字化:
|
ボリューム (24 時間):